Literature DB >> 9234703

Kinase-deficient Pak1 mutants inhibit Ras transformation of Rat-1 fibroblasts.

Y Tang1, Z Chen, D Ambrose, J Liu, J B Gibbs, J Chernoff, J Field.   

Abstract

Among the mechanisms by which the Ras oncogene induces cellular transformation, Ras activates the mitogen-activated protein kinase (MAPK or ERK) cascade and a related cascade leading to activation of Jun kinase (JNK or SAPK). JNK is additionally regulated by the Ras-related G proteins Rac and Cdc42. Ras also regulates the actin cytoskeleton through an incompletely elucidated Rac-dependent mechanism. A candidate for the physiological effector for both JNK and actin regulation by Rac and Cdc42 is the serine/threonine kinase Pak (p65pak). We show here that expression of a catalytically inactive mutant Pak, Pak1(R299), inhibits Ras transformation of Rat-1 fibroblasts but not of NIH 3T3 cells. Typically, 90 to 95% fewer transformed colonies were observed in cotransfection assays with Rat-1 cells. Pak1(R299) did not inhibit transformation by the Raf oncogene, indicating that inhibition was specific for Ras. Furthermore, Rat-1 cell lines expressing Pak1(R299) were highly resistant to Ras transformation, while cells expressing wild-type Pak1 were efficiently transformed by Ras. Pak1(L83,L86,R299), a mutant that fails to bind either Rac or Cdc42, also inhibited Ras transformation. Rac and Ras activation of JNK was inhibited by Pak1(R299) but not by Pak1(L83,L86,R299). Ras activation of ERK was inhibited by both Pak1(R299) and Pak1(L83,L86,R299), while neither mutant inhibited Raf activation of ERK. These results suggest that Pak1 interacts with components essential for Ras transformation and that inhibition can be uncoupled from JNK but not ERK signaling.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234703      PMCID: PMC232299          DOI: 10.1128/MCB.17.8.4454

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

1.  Emerging from the Pak: the p21-activated protein kinase family.

Authors:  M A Sells; J Chernoff
Journal:  Trends Cell Biol       Date:  1997-04       Impact factor: 20.808

2.  Critical role of Rho in cell transformation by oncogenic Ras.

Authors:  G C Prendergast; R Khosravi-Far; P A Solski; H Kurzawa; P F Lebowitz; C J Der
Journal:  Oncogene       Date:  1995-06-15       Impact factor: 9.867

3.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.

Authors:  M Hibi; A Lin; T Smeal; A Minden; M Karin
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

4.  The pathway to signal achievement.

Authors:  S E Egan; R A Weinberg
Journal:  Nature       Date:  1993-10-28       Impact factor: 49.962

Review 5.  Transcriptional regulation by extracellular signals: mechanisms and specificity.

Authors:  C S Hill; R Treisman
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

6.  RAC regulation of actin polymerization and proliferation by a pathway distinct from Jun kinase.

Authors:  T Joneson; M McDonough; D Bar-Sagi; L Van Aelst
Journal:  Science       Date:  1996-11-22       Impact factor: 47.728

7.  Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1.

Authors:  S Zhang; J Han; M A Sells; J Chernoff; U G Knaus; R J Ulevitch; G M Bokoch
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

Review 8.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

9.  Thyrotropin-induced mitogenesis is Ras dependent but appears to bypass the Raf-dependent cytoplasmic kinase cascade.

Authors:  N al-Alawi; D W Rose; C Buckmaster; N Ahn; U Rapp; J Meinkoth; J R Feramisco
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

10.  A human protein selected for interference with Ras function interacts directly with Ras and competes with Raf1.

Authors:  L Han; J Colicelli
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

View more
  57 in total

1.  S338 phosphorylation of Raf-1 is independent of phosphatidylinositol 3-kinase and Pak3.

Authors:  A Chiloeches; C S Mason; R Marais
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Regulation of macropinocytosis by p21-activated kinase-1.

Authors:  S Dharmawardhane; A Schürmann; M A Sells; J Chernoff; S L Schmid; G M Bokoch
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

3.  Pak1 and PIX regulate contact inhibition during epithelial wound healing.

Authors:  Mirjam M P Zegers; Marie-Annick Forget; Jonathan Chernoff; Keith E Mostov; Martin B A ter Beest; Steen H Hansen
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

Review 4.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

Review 5.  Molecular pathways: targeting p21-activated kinase 1 signaling in cancer--opportunities, challenges, and limitations.

Authors:  Jeyanthy Eswaran; Da-Qiang Li; Anil Shah; Rakesh Kumar
Journal:  Clin Cancer Res       Date:  2012-05-17       Impact factor: 12.531

6.  Autophosphorylation-dependent degradation of Pak1, triggered by the Rho-family GTPase, Chp.

Authors:  Monika Weisz Hubsman; Natalia Volinsky; Edward Manser; Deborah Yablonski; Ami Aronheim
Journal:  Biochem J       Date:  2007-06-15       Impact factor: 3.857

7.  Identification of phosphorylation sites in betaPIX and PAK1.

Authors:  Mark W Mayhew; Erin D Jeffery; Nicholas E Sherman; Kristina Nelson; Joy M Polefrone; Stephen J Pratt; Jeffrey Shabanowitz; J Thomas Parsons; Jay W Fox; Donald F Hunt; Alan F Horwitz
Journal:  J Cell Sci       Date:  2007-11-15       Impact factor: 5.285

8.  An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase.

Authors:  Sean W Deacon; Alexander Beeser; Jami A Fukui; Ulrike E E Rennefahrt; Cynthia Myers; Jonathan Chernoff; Jeffrey R Peterson
Journal:  Chem Biol       Date:  2008-04

9.  PAK promotes morphological changes by acting upstream of Rac.

Authors:  A Obermeier; S Ahmed; E Manser; S C Yen; C Hall; L Lim
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

10.  Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2.

Authors:  Chunling Yi; Erik W Wilker; Michael B Yaffe; Anat Stemmer-Rachamimov; Joseph L Kissil
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.